Keywords: Liver, Liver
Motivation: Evaluate the performance of the LI-RADS v2018 features and clinical-pathological factors for predicting the prognosis of AFP-negative HCC.
Goal(s): To evaluate the performance of the LI-RADS v2018 features and clinical-pathological factors for predicting the prognosis of AFP-negative HCC.
Approach: A total of 169 AFP-negative HCC patients were enrolled. Risk factors associated with prognosis were identified by Cox regression analysis.
Results: Six risk factors, namely the LI-RADS category, blood products in mass, MVI, tumor size, cirrhosis, and ALBI grade, were associated with recurrence-free survival. The model effectively stratified patients with AFP-negative HCC into high- and low-risk groups with significantly different outcomes (p < 0.05).
Impact: In this study, our prognostic model composed of the LI-RADS category, blood products in mass, MVI, tumor size, cirrhosis, and ALBI grade accurately classified patients into different recurrence risk groups.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords